SCHEMBL7380802

SCHEMBL7380802

Cc1cc(C[CH]Cc2cccnc2)cc(NC=O)c1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.44
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NAMPT P43490 2/20 0.39
TSHR P16473 2/20 0.38
HTT P42858 1/20 0.38
VNN1 O95497 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7378072 0.77 AR (0.42) MAPTALDH1A1CYP1A2TSHRVNN1
SCHEMBL7381052 0.76 VNN1 (0.46) ALDH1A1TDP1TSHRHTTVNN1
SCHEMBL7382585 0.74 MEN1 (0.47) ALDH1A1CYP1A2CYP2D6TDP1POLB
SCHEMBL7380717 0.72 CHRNA7 (0.42) ALDH1A1CYP1A2CYP2D6TDP1L3MBTL1
SCHEMBL8726941 0.69 LTA4H (0.52) CYP1A2CYP2D6
SCHEMBL7384351 0.69 CYP1A2 (0.43) CYP1A2CYP2D6TDP1L3MBTL1HTT
SCHEMBL7381665 0.69 MAPT (0.47) MAPTALDH1A1CYP1A2CYP2D6
SCHEMBL7379652 0.69 ALDH1A1 (0.33) MAPTALDH1A1KDM4E
SCHEMBL272335 0.69
SCHEMBL7384248 0.69 HTR1A (0.45) ALDH1A1CYP1A2TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed